1. Home
  2. SYRE vs WOLF Comparison

SYRE vs WOLF Comparison

Compare SYRE & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • WOLF
  • Stock Information
  • Founded
  • SYRE 2013
  • WOLF 1987
  • Country
  • SYRE United States
  • WOLF United States
  • Employees
  • SYRE N/A
  • WOLF N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • WOLF Semiconductors
  • Sector
  • SYRE Health Care
  • WOLF Technology
  • Exchange
  • SYRE Nasdaq
  • WOLF Nasdaq
  • Market Cap
  • SYRE 897.9M
  • WOLF 978.5M
  • IPO Year
  • SYRE 2016
  • WOLF 1993
  • Fundamental
  • Price
  • SYRE $12.67
  • WOLF $2.47
  • Analyst Decision
  • SYRE Buy
  • WOLF Hold
  • Analyst Count
  • SYRE 8
  • WOLF 15
  • Target Price
  • SYRE $50.00
  • WOLF $13.15
  • AVG Volume (30 Days)
  • SYRE 899.5K
  • WOLF 30.1M
  • Earning Date
  • SYRE 05-08-2025
  • WOLF 04-30-2025
  • Dividend Yield
  • SYRE N/A
  • WOLF N/A
  • EPS Growth
  • SYRE N/A
  • WOLF N/A
  • EPS
  • SYRE N/A
  • WOLF N/A
  • Revenue
  • SYRE N/A
  • WOLF $776,600,000.00
  • Revenue This Year
  • SYRE N/A
  • WOLF N/A
  • Revenue Next Year
  • SYRE N/A
  • WOLF $27.27
  • P/E Ratio
  • SYRE N/A
  • WOLF N/A
  • Revenue Growth
  • SYRE N/A
  • WOLF N/A
  • 52 Week Low
  • SYRE $10.91
  • WOLF $2.06
  • 52 Week High
  • SYRE $40.49
  • WOLF $30.86
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 36.18
  • WOLF 36.02
  • Support Level
  • SYRE $12.04
  • WOLF $2.08
  • Resistance Level
  • SYRE $13.29
  • WOLF $2.89
  • Average True Range (ATR)
  • SYRE 1.27
  • WOLF 0.33
  • MACD
  • SYRE 0.01
  • WOLF 0.00
  • Stochastic Oscillator
  • SYRE 26.02
  • WOLF 37.61

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

Share on Social Networks: